{
    "clinical_study": {
        "@rank": "106039", 
        "brief_summary": {
            "textblock": "This study will investigate how the use of Tranexamic acid and Bacitracin applied to the\n      bleeding site after the hemodialysis fistula needle is removed will affect skin wound\n      healing."
        }, 
        "brief_title": "Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Native Arteriovenous Fistula", 
        "condition_browse": {
            "mesh_term": [
                "Arteriovenous Fistula", 
                "Fistula"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Dialysis patients with fistulas (native arterio-venous)\n\n        Exclusion Criteria:\n\n          -  Previous sensitivity to or adverse reaction to Tranexamic acid or Bacitracin.\n\n          -  Active infection.\n\n          -  Stenosis of fistula."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02106962", 
            "org_study_id": "001-Boiskin"
        }, 
        "intervention": [
            {
                "description": "A fixed amount of tranexamic acid and bacitracin will be applied with compression up to 3 times (13 minutes total) per hemodialysis fistula needle site per visit (8 visits total).", 
                "intervention_name": "Topical Tranexamic Acid", 
                "intervention_type": "Drug", 
                "other_name": "Cyklokapron"
            }, 
            {
                "description": "A fixed amount of tranexamic acid and bacitracin will be applied with compression up to 3 times (13 minutes total) per hemodialysis fistula needle site per visit (8 visits total).", 
                "intervention_name": "Topical Bacitracin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bacitracin", 
                "Tranexamic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemodialysis", 
            "fistula", 
            "clotting", 
            "tranexamic acid", 
            "bacitracin"
        ], 
        "lastchanged_date": "April 9, 2014", 
        "location": [
            {
                "contact": {
                    "email": "clorenzo@cairr.com", 
                    "last_name": "Christina Lorenzo, BS", 
                    "phone": "858-637-4600"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92123"
                    }, 
                    "name": "California Insitute of Renal Research"
                }, 
                "investigator": [
                    {
                        "last_name": "Mark Boiskin, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Christian Mende, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dylan Steer, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lbuchard@cairr.com", 
                    "last_name": "Buchard"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92111"
                    }, 
                    "name": "Fresenius Medical Care - Kearny Mesa"
                }, 
                "investigator": [
                    {
                        "last_name": "Mark Boiskin, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Christian Mende, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dylan Steer, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lbuchard@cairr.com", 
                    "last_name": "Buchard"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92127"
                    }, 
                    "name": "Fresenious Medical Care - Rancho"
                }, 
                "investigator": [
                    {
                        "last_name": "Mark Boiskin, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Christian Mende, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dylan Steer, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients", 
        "overall_contact": {
            "email": "clorenzo@cairr.com", 
            "last_name": "Christina Lorenzo, BS", 
            "phone": "858-637-4600"
        }, 
        "overall_official": {
            "affiliation": "California Institute of Renal Research", 
            "last_name": "Mark Boiskin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clotting Time", 
            "safety_issue": "No", 
            "time_frame": "13 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02106962"
        }, 
        "responsible_party": {
            "investigator_affiliation": "California Institute of Renal Research", 
            "investigator_full_name": "Mark Boiskin", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Bleeding Time", 
                "safety_issue": "No", 
                "time_frame": "13 minutes"
            }, 
            {
                "measure": "Blood Loss", 
                "safety_issue": "Yes", 
                "time_frame": "13 minutes"
            }, 
            {
                "measure": "Local Compression Time", 
                "safety_issue": "No", 
                "time_frame": "13 Minutes"
            }, 
            {
                "measure": "Local Infection", 
                "safety_issue": "Yes", 
                "time_frame": "2 months"
            }
        ], 
        "source": "California Institute of Renal Research", 
        "sponsors": {
            "collaborator": {
                "agency": "Imprimis Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "California Institute of Renal Research", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}